When challenged by exposure to the BCL-2 inhibitor, VEN-sensitive samples showed a rapid reduction of basal and ATP-linked respiration, whereas VEN-resistant samples were able to compensate drug-induced impairment of mitochondrial metabolic activity, indicating reprogramming of mitochondrial metabolism in VEN-resistant leukemia. Here, BCL2 is linked to leukemia.